Osimertinib Plus Bevacizumab Versus Osimertinib for Untreated Nonsquamous NSCLC Harboring EGFR Mutations

Zhao, BH; Xing, H; Ma, WB

Zhao, BH (通讯作者),Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Neurosurg, Beijing 100730, Peoples R China.

JOURNAL OF THORACIC ONCOLOGY, 2022; 17 (9): E76